Registry screening aims to close gaps in heart failure care

NCT ID NCT07154758

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study uses the Swedish Heart Failure Registry to identify people with heart failure and reduced ejection fraction who may need medication adjustments, iron deficiency screening, device therapy, or physiotherapy. Researchers will compare outcomes for 500 patients who receive this registry-based screening and referral to 500 patients receiving usual care. The goal is to see if this approach helps more patients get the treatments they need.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
registry-based screening and referral for guideline-directed medical therapy optimization
What this could lead to
If successful, this approach could help more heart failure patients receive optimal medications and treatments, potentially improving survival and quality of life.
What could go wrong
This is an early-stage implementation study, not testing a new drug. Success depends on whether screening and referral actually change outcomes in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hemse vårdcentral

    RECRUITING

    Hemse, Sweden

  • Karolinska University Hospital

    RECRUITING

    Stockholm, Sweden

  • Länssjukhuset Ryhov

    RECRUITING

    Jönköping, Sweden

  • Sahlgrenska Universitetssjukhuset

    RECRUITING

    Gothenburg, Sweden

  • St Görans hospital

    RECRUITING

    Stockholm, Sweden

  • Södersjukhuset

    RECRUITING

    Stockholm, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.